BioNexus Gene Lab Corp. (BGLC) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

BioNexus Gene Lab Corp.

NASDAQ: BGLC · Real-Time Price · USD
5.32
-0.04 (-0.75%)
At close: Oct 03, 2025, 3:59 PM
5.26
-1.13%
After-hours: Oct 03, 2025, 07:53 PM EDT

BioNexus Gene Lab Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-2.93M -2.12M -1.6M -942.61K -2.21M -2.66M -2.63M -3.09M -562.69K -442.1K -355.97K -109.75K 262.97K 429.89K 751.57K 1.93M 1.58M 1.48M
Depreciation & Amortization
173.85K 163.58K 153.14K 139.77K 119.99K 113.14K 108.42K 104.82K 101.37K 103.64K 105.42K 105.88K 106.86K 119.81K 108.22K 144.53K 131.06K 103.52K
Stock-Based Compensation
n/a n/a n/a -88.95K -88.95K -88.95K -88.95K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
-158.48K -818.45K -355.23K -512.54K -433.23K 321.15K -176.11K 648.47K 332.5K -409.63K -249.37K -1.35M -1.04M -1.04M -1.1M -1.15M -770.64K -1.23M
Other Non-Cash Items
-342.16K -867.54K -904.46K -1.22M 508.05K 1.27M 1.19M 1.58M 58.64K -74.15K -33.29K 106.63K 51.77K 17.44K 11.62K -748.86K -744.84K -750.58K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
14.69K -199.3K 115.4K -310.72K -203.34K 149.9K 117.98K 845.68K 1.05M 883.48K 833.38K 455.34K 143.47K -711.25K -862.25K -1.09M -1.1M -120.96K
Operating Cash Flow
-3.09M -3.02M -2.23M -2.43M -1.87M -1.22M -1.3M -565.22K 643.02K 470.87K 549.55K 558.09K 565.07K -144.11K 9.16K 233.74K 672.62K 1.42M
Capital Expenditures
-233.72K -214.1K -226.99K -223.9K -158.72K -171.24K -149.4K -165.49K -35.15K -22.08K -54.17K -38.42K -35.17K -34.55K -3.16K -423.5K -423.09K -422.43K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-297.83K -392.4K -571.57K -510.79K -612.26K -501.78K -320.73K -409.84K -120.36K -353.18K -511.71K -481.52K -548.87K -391.99K -515.84K -432.29K -370.42K -302.31K
Sales Maturities Of Investments
771.1K 857.43K 1.07M 494.03K 323.82K 237.49K 26.15K 26.85K n/a n/a n/a -22 -74 -74 -74 30.01K 29.83K 29.83K
Other Investing Acitivies
27.31K 107.77K 107.78K 110.76K 139.65K 61.66K 61.41K 129.75K 115.84K 116.84K 115.38K 43.08K 30.3K 34.73K 28.5K 1.76M 1.76M 1.77M
Investing Cash Flow
266.86K 358.71K 378K -129.91K -307.5K -373.87K -382.58K -418.73K -39.66K -258.42K -450.5K -476.88K -553.82K -391.88K -490.57K 905.71K 968.67K 1.05M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a -34.04K -34.04K -39K -44.99K -17.75K -26.3K -20.39K -12.69K -8.51K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-59.18K -59.18K -59.18K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-75 176.37K 204.16K 9.5K 210.88K 33.03K 4.32K -6.79K -5.95K 146.49K 148.26K 148.26K 149.92K -1.92K -1.92K -2.22K -1.83K -374
Financial Cash Flow
-59.26K 117.19K 144.97K 9.5K 5.96M 5.78M 5.75M 5.74M -5.95K 112.45K 114.23K 109.27K 104.92K -19.67K -28.22K -22.61K -14.34K -8.7K
Net Cash Flow
-3.88M -3.8M -3.08M -2.05M 3.62M 3.88M 3.81M 4.68M 418.35K 128.89K -5.05K -238.13K -142.37K -630.34K -663.77K 1.01M 1.7M 2.58M
Free Cash Flow
-3.32M -3.24M -2.46M -2.65M -2.03M -1.39M -1.45M -730.71K 607.87K 448.79K 495.38K 519.67K 529.89K -178.65K 6K -189.76K 249.52K 998.14K